Lung cancer screening guidelines should be expanded, according to a multispecialty task force established by the American Association for Thoracic Surgery.
Lung cancer screening guidelines should be expanded, according to a multispecialty task force established by the American Association for Thoracic Surgery. The recommendations were published last week in the online issue of the Journal of Thoracic and Cardiovascular Surgery.
Guidelines published this past May by the American College of Chest Physicians don’t go far enough and they do not include lung cancer survivors, according to the 14-member AATS task force comprising thoracic surgeons, thoracic radiologists, medical oncologists, a pulmonologist, a pathologist, and an epidemiologist.
The new recommendations include instituting annual lung cancer screening using low-dose computed tomography (LDCT) for:
- Smokers and former smokers who are between the ages of 55 and 79 who have smoked the equivalent of a pack of cigarettes every day for 30 years; (The guidelines stopped at age 74.)
- Smokers and former smokers who are between the ages of 50 and 70 who have smoked the equivalent of a pack per day for 20 years and have other factors that raise their risk of developing lung cancer;
- Lung cancer survivors up to the age of 79.
Some concern remains regarding dose-radiation exposure to patients over repeated screenings. However, there has been progress developing procedures that do not expose patients as much as in the past, and efforts to further reduce radiation are continuing.
“Low-dose CT scanning has been proven to save lives,” said Francine Jacobson, MD, MPH, a thoracic radiologist at Brigham and Women’s Hospital and a co-chair of the task force. “I hope this recommendation will encourage physicians to use low-dose CT scanning for a broader range of patients.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.